Using Protein Interactome Networks to Understand the Functional Role of Coding DN
Using Protein Interactome Networks to Understand the Functional Role of Coding DN
批准号:
8706913
负责人:
Steven M Lipkin
金额:
$41.11万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2017-05-31
关键词:
AffectBenignBiological AssayBiotechnologyCalibrationCandidate Disease GeneCell Culture TechniquesCellsClinicalCodeComplexComputational algorithmCounselingCrohn&aposs diseaseDNA SequenceDataData SetDatabasesDetectionDiseaseFamilyFamily memberGene MutationGenesGenetic EpistasisGenetic PolymorphismGenomeGoalsHealthHereditary DiseaseHuman GeneticsHybridsImmunologic Deficiency SyndromesIndividualMedicalMutationNatureNon-Hodgkin&aposs LymphomaOnline Mendelian Inheritance In ManOutcomePathway interactionsPatientsPhenotypePropertyProteinsPublishingRoleSystemSystems BiologyTestingValidationVariantWritingbasecombinatorialdisorder riskexomeexome sequencingexperiencefollow-upgain of functiongenetic variantgenome sequencingimprovedinnovationkindredloss of functionmutantnovel strategiesrare variantrisk variantsegregationsuccesstooltrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recent whole exome and genome sequencing studies, including our own, have revealed that both healthy individuals and those affected by genetic diseases carry many rare DNA sequence variants. They classify them correctly as either bona fide causal mutations for genetic diseases, or merely benign polymorphisms. New approaches are clearly needed to filter through candidate sequence variants identified in whole exome/genome studies to identify causal mutations and evaluate their epistatic interactions in human genetic diseases, particularly complex traits. Building upon the experience of the PIs, we propose an innovative hybrid computational-experimental systems.The high-throughput 3DIP strategy can classify coding genetic variants as causative mutations or benign polymorphisms and evaluate epistatic interactions that can be broadly applied to human genetic diseases, including complex traits. Our overall goal is to develop a high-throughput approach that can accurately validate coding genetic variants as causal mutations or merely benign polymorphisms to improve exome study success rates. Our long-term goal is to apply this approach to improve the medical outcomes of patients and their family members who carry variants of uncertain significance in genetic disease risk genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lynch Vaccine
-
批准号:10505678
-
项目类别:
-
资助金额:$44.11万
-
财政年份:2022
-
负责人:Steven M Lipkin
-
依托单位:
CAP-IT CRI U54 ADMINISTRATIVE CORE
-
批准号:10505676
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2022
-
负责人:Steven M Lipkin
-
依托单位:
Cancer Immune-Interception for Lynch Syndrome
-
批准号:10491665
-
项目类别:
-
资助金额:$66.19万
-
财政年份:2021
-
负责人:Steven M Lipkin
-
依托单位:
Cancer Immune-Interception for Lynch Syndrome
-
批准号:10706565
-
项目类别:
-
资助金额:$66.01万
-
财政年份:2021
-
负责人:Steven M Lipkin
-
依托单位:
Elucidating the Role of MALAT1 Somatic Driver Mutations in Colorectal Cancer
-
批准号:10307526
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Elucidating the Role of MALAT1 Somatic Driver Mutations in Colorectal Cancer
-
批准号:10056203
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
-
批准号:9789215
-
项目类别:
-
资助金额:$71.75万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
-
批准号:10478171
-
项目类别:
-
资助金额:$78.03万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance
-
批准号:10229450
-
项目类别:
-
资助金额:$50.32万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Elucidating the Role of MALAT1 Somatic Driver Mutations in Colorectal Cancer
-
批准号:10532219
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
-
批准号:10240627
-
项目类别:
-
资助金额:$63.81万
-
财政年份:2018
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF ANTI FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER IMMUNOPREVENTION
-
批准号:9358850
-
项目类别:
-
资助金额:$42.34万
-
财政年份:2016
-
负责人:Steven M Lipkin
-
依托单位:
ANTI FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER IMMUNOPREVENTION
-
批准号:10006480
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2016
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF ANTI FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER IMMUNOPREVENTION
-
批准号:9563035
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2016
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME GASTROINTESTINAL CANCER
-
批准号:9443551
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2015
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME GASTROINTESTINAL CANCER
-
批准号:9162495
-
项目类别:
-
资助金额:$68.0万
-
财政年份:2015
-
负责人:Steven M Lipkin
-
依托单位:
IGF::OT::IGF Base Contract Title: Preclinical In Vitro and In Vivo Agent Development Assays, Task Order Title: A Polyvalent Vaccine Against Fusion Proteins Observed in Solid Tumors, Period of Perfo
-
批准号:8941109
-
项目类别:
-
资助金额:$45.86万
-
财政年份:2014
-
负责人:Steven M Lipkin
-
依托单位:
Using Protein Interactome Networks to Understand the Functional Role of Coding DN
-
批准号:8431489
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2013
-
负责人:Steven M Lipkin
-
依托单位:
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes
-
批准号:8438623
-
项目类别:
-
资助金额:$39.24万
-
财政年份:2012
-
负责人:Steven M Lipkin
-
依托单位:
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes
-
批准号:8681393
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2012
-
负责人:Steven M Lipkin
-
依托单位:
海外基金